Advancing excellence in laboratory medicine for better healthcare worldwide
Cell free DNA and related circulating biomarkers (WG-cfDNA)
Membership
| Name | Position | Country | Term | Time in Office |
| R. van Schaik | Chair | NL | 2nd | 2021 01 - 2023 12 |
| M. del Re | Member | IT | ||
| S. Galbiati | Member | IT | ||
| E. Lianidou | Member | GR | ||
| M. Neumaier | Member | DE | ||
| D. Lo | Member | HK | ||
| M. Oellerich | Member | DE |
Terms of Reference
-
To identify and provide guidance on preanalytical and analytical aspects for obtaining good and reproducible results for cfDNA and related circulating biomarkers for clinical use, and to guide the correct clinical implementation of these biomarkers.
Current projects
- a) Defining pre-analytical aspects / drafting guideline
- b) Defining minimal analytical performance
- c) Setting up proficiency testing for cfDNA
- e) Organizing international workshops
- f) Defining grant proposals to address unmet needs under a) and b)
List of Corresponding Members, nominated by National Societies
| Name | Full and Affiliate Member Societies |
| Oytun Portakal | Turkish Biochemical Society (TBS) |
List of Corresponding Members, nominated by Corporate Members
| Name | Corporate Members |
| Laura Vaahtoranta | MEDIX BIOCHEMICA |
| Mana Javey | ROCHE |
Working Group Chair's contact
Prof. dr. Ron HN VAN SCHAIK, PhD/FACB/EuSpLM
Professor of Pharmacogenetic
Erasmus University Medical Center Rotterdam
Room Na-415 - Wytemaweg 80
3015CN Rotterdam
The Netherlands
Tel.: +31 10 70 33119
Email: r.vanschaik@erasmusmc.nl